Literature DB >> 8707314

Human papillomaviruses and cervical screening.

I J Etherington, M I Shafi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707314      PMCID: PMC1195641          DOI: 10.1136/sti.72.3.153

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


× No keyword cloud information.
  12 in total

1.  High rate of human papillomavirus type 16 infection in cytologically normal cervices.

Authors:  J A Tidy; G C Parry; P Ward; D V Coleman; J Peto; A D Malcolm; P J Farrell
Journal:  Lancet       Date:  1989-02-25       Impact factor: 79.321

2.  Accelerated decline in cervical cancer mortality in England and Wales.

Authors:  P Sasieni; J Cuzick; E Farmery
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

3.  Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study.

Authors:  M Lehtinen; J Dillner; P Knekt; T Luostarinen; A Aromaa; R Kirnbauer; P Koskela; J Paavonen; R Peto; J T Schiller; M Hakama
Journal:  BMJ       Date:  1996-03-02

4.  Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Authors:  J T Cox; A T Lorincz; M H Schiffman; M E Sherman; A Cullen; R J Kurman
Journal:  Am J Obstet Gynecol       Date:  1995-03       Impact factor: 8.661

5.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

Authors:  M H Schiffman; H M Bauer; R N Hoover; A G Glass; D M Cadell; B B Rush; D R Scott; M E Sherman; R J Kurman; S Wacholder
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

6.  Management of women with mild and moderate cervical dyskaryosis.

Authors:  G Flannelly; D Anderson; H C Kitchener; E M Mann; M Campbell; P Fisher; F Walker; A A Templeton
Journal:  BMJ       Date:  1994-05-28

7.  Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.

Authors:  G Y Ho; R D Burk; S Klein; A S Kadish; C J Chang; P Palan; J Basu; R Tachezy; R Lewis; S Romney
Journal:  J Natl Cancer Inst       Date:  1995-09-20       Impact factor: 13.506

8.  Human papillomavirus testing in primary cervical screening.

Authors:  J Cuzick; A Szarewski; G Terry; L Ho; A Hanby; P Maddox; M Anderson; G Kocjan; S T Steele; J Guillebaud
Journal:  Lancet       Date:  1995-06-17       Impact factor: 79.321

9.  Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.

Authors:  P J Bavin; J A Giles; A Deery; J Crow; P D Griffiths; V C Emery; P G Walker
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

10.  Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia.

Authors:  J Cuzick; G Terry; L Ho; T Hollingworth; M Anderson
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

View more
  1 in total

1.  Cervical cytology and colposcopy in clinics for sexually transmitted diseases--when are they appropriate?

Authors:  J D Wilson
Journal:  Genitourin Med       Date:  1996-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.